SEM · As filed with the SEC
Select Medical Holdings income statement, by fiscal year
The statement as Select Medical Holdings presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Operations · USD thousands, except per-share amounts
| USD thousands, except per-share amounts | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 |
|---|---|---|---|---|
| Revenue | 5,452,830 | 5,187,105 | 6,664,058 | 6,333,538 |
| Costs and expenses: | ||||
| Cost of services, exclusive of depreciation and amortization | 4,823,535 | 4,553,461 | 5,732,017 | 5,600,161 |
| General and administrative | 154,414 | 225,869 | 170,193 | 153,035 |
| Depreciation and amortization | — | — | 208,742 | 205,825 |
| Depreciation and amortization | 140,303 | 142,866 | — | — |
| Total costs and expenses | 5,118,252 | 4,922,196 | 6,110,952 | 5,959,021 |
| Other operating income | 1,592 | 3,406 | 1,768 | 28,766 |
| Income from continuing operations before other income and expense | 336,170 | 268,315 | 554,874 | 403,283 |
| Other income and expense: | ||||
| Loss on early retirement of debt | 0 | (28,845) | (14,692) | — |
| Equity in earnings of unconsolidated subsidiaries | — | — | 40,813 | 26,407 |
| Gain on sale of businesses | — | — | 0 | 0 |
| Interest income | — | — | 0 | 0 |
| Interest expense | — | — | (198,639) | (169,111) |
| Equity in earnings of unconsolidated subsidiaries | 54,521 | 63,904 | — | — |
| Interest expense | (117,942) | (128,605) | — | — |
| Income from continuing operations before income taxes | 272,749 | 174,769 | 382,356 | 260,579 |
| Income tax expense from continuing operations | 58,216 | 44,782 | 82,625 | 62,553 |
| Income from continuing operations, net of tax | 214,533 | 129,987 | — | — |
| Discontinued operations: | ||||
| Income from discontinued business | 0 | 223,414 | — | — |
| Income tax expense from discontinued business | 0 | 56,697 | — | — |
| Income from discontinued operations, net of tax | 0 | 166,717 | — | — |
| Net income | 214,533 | 296,704 | 299,731 | 198,026 |
| Less: Net income attributable to non-controlling interests | 68,314 | 82,666 | 56,240 | 39,032 |
| Net income attributable to Select Medical Holdings Corporation | 146,219 | 214,038 | 243,491 | 158,994 |
| Net income attributable to Select Medical Holdings Corporation’s common stockholders: | ||||
| Income from continuing operations, net of tax | 146,219 | 65,473 | — | — |
| Income from discontinued operations, net of tax | 0 | 148,565 | — | — |
| Earnings (loss) per common share | ||||
| Continuing operations - basic (in dollars per share) | 1.16 | 0.51 | — | — |
| Continuing operations - diluted (in dollars per share) | 1.16 | 0.51 | — | — |
| Discontinued operations - basic (in dollars per share) | 0.00 | 1.15 | — | — |
| Discontinued operations - diluted (in dollars per share) | 0.00 | 1.15 | — | — |
| Total earnings per common share - basic (in dollars per share) | 1.16 | 1.66 | 1.91 | 1.23 |
| Total earnings per common share - diluted (in dollars per share) | 1.16 | 1.66 | 1.91 | 1.23 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.